Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556550054> ?p ?o ?g. }
- W2556550054 abstract "Abstract Abstract 1300 Background: BACH2 (BTB and CNC homology 1, basic leucine zipper transcription factor 2) is required for class-switch recombination and somatic hypermutation of immunoglobulin genes during affinity maturation of mature germinal center B cells. We and others found that BACH2 is strongly upregulated in BCR-ABL1-transformed acute lymphoblastic leukemia (Ph+ ALL) cells upon treatment with tyrosine kinase inhibitors (TKI). Results: Bach2 mRNA levels are significantly lower in Ph+ ALL (n=72) compared to normal human bone marrow pre-B cells (n=10). Studying gene expression in a clinical trial for children with high risk ALL (Children's Oncology Group, P9906; n=207), we found in a multivariate analysis that high Bach2 levels at the time of diagnosis represents an independent predictor of favorable clinical outcome (negative MRD at day and higher overall and relapse-free survival; p<0.0001). We next studied 49 sample pairs from patients with childhood ALL at diagnosis and relapse. In 44 of these sample pairs, the relapse sample showed drastically reduced mRNA levels of Bach2 (p=0.019), suggesting that loss of BACH2 expression is associated with relapse of childhood ALL. A comparison of the methylation status of BACH2 promoter of normal pre-B cells (n=5), with Ph+ ALL cells (n=70) revealed that CpG islands in the BACH2 promoter were heavily hypermethylated in the leukemia samples. These findings are also consistent with genomic analyses on patient derived samples and the identification of small deletions at 6q15 in 4 of 11 cases of childhood ALL cases that all span the BACH2 locus. To study the role of Bach2 in pre-B ALL in a genetic experiment, we transformed pre-B cells from Bach2−/− mice with BCR-ABL1. We observed that Bach2−/− normal pre-B cells lack the ability to counterselect pre-B cell clones that failed to undergo successful V(D)J rearrangement. In the absence of Bach2, a significant number of B cells survive even though they failed to rearrange immunoglobulin heavy chain genes. Besides this unexpected role in early B cell differentiation, quantitative RT-PCR and Western blot confirmed that BACH2 is also required for expression of the tumor suppressors Cdkn2a (Arf), p53 and Btg2. Consistent with extremely low protein levels of Arf and p53 in Bach2−/− leukemia cells, Bach2−/− ALL cells are more resistant to TKI-treatment, more actively proliferating (increased S-phase; p=0.02) and exhibit a ∼90-fold increased ability to form colonies in methyl cellulose (p=0.001). Studying Cre-mediated inducible deletion of p53 in p53-fl/fl leukemia cells, we found that Bach2-induced tumor suppression is largely dependent on p53 function. Forced overexpression of Myc results in oncogene-induced senescence (OIS) followed by apoptosis. Whereas Bach2+/+ leukemia cells are non-permissive to forced Myc expression and die within four days after Myc induction, Bach2−/− ALL cells tolerate forced expression of Myc and evade OIS and subsequent cell death. Similarly, overexpression of Myc alone fails to transform Bach2+/+ pre-B cells. By contrast, retroviral overexpression of Myc results in rapid transformation and growth factor-independence of Bach2−/− pre-B cells. Bach2−/− Myc-high pre-B cells cause fatal leukemia in 100% of recipient mice within 22 days, whereas all mice that received Bach2+/+ Myc-high pre-B cells survived without signs of disease until day 67, when all mice were sacrificed and analyzed for MRD by flow cytometry and PCR. No evidence of MRD was detected in most mice injected with Bach2+/+ Myc-high pre-B cells. Three mice had positive MRD PCR findings, however, at 4 log orders below findings in mice injected with Bach2−/−Myc-high pre-B cells. Conclusions: Our findings identify Bach2 as a novel tumor suppressor upstream of p53 in pre-B ALL. Bach2 is a regulator of negative selection during normal pre-B cell differentiation but also limits excessive proliferation of pre-B cell clones by induction of oncogene-induced senescence and activation of p53. In addition, our multivariate analyses identify high expression levels of Bach2 as powerful predictor of favorable clinical outcome in children, which may be useful in future approaches for risk stratification. Disclosures: No relevant conflicts of interest to declare." @default.
- W2556550054 created "2016-11-30" @default.
- W2556550054 creator A5017501168 @default.
- W2556550054 creator A5019770989 @default.
- W2556550054 creator A5020303646 @default.
- W2556550054 creator A5034669735 @default.
- W2556550054 creator A5034755041 @default.
- W2556550054 creator A5037432090 @default.
- W2556550054 creator A5049679155 @default.
- W2556550054 creator A5050087793 @default.
- W2556550054 creator A5061732223 @default.
- W2556550054 creator A5070576060 @default.
- W2556550054 creator A5074664283 @default.
- W2556550054 creator A5080485119 @default.
- W2556550054 creator A5081605030 @default.
- W2556550054 date "2012-11-16" @default.
- W2556550054 modified "2023-09-27" @default.
- W2556550054 title "BACH2 Is Required for Pre-B Cell Receptor Checkpoint Control and p53-Dependent Tumor Surveillance" @default.
- W2556550054 doi "https://doi.org/10.1182/blood.v120.21.1300.1300" @default.
- W2556550054 hasPublicationYear "2012" @default.
- W2556550054 type Work @default.
- W2556550054 sameAs 2556550054 @default.
- W2556550054 citedByCount "0" @default.
- W2556550054 crossrefType "journal-article" @default.
- W2556550054 hasAuthorship W2556550054A5017501168 @default.
- W2556550054 hasAuthorship W2556550054A5019770989 @default.
- W2556550054 hasAuthorship W2556550054A5020303646 @default.
- W2556550054 hasAuthorship W2556550054A5034669735 @default.
- W2556550054 hasAuthorship W2556550054A5034755041 @default.
- W2556550054 hasAuthorship W2556550054A5037432090 @default.
- W2556550054 hasAuthorship W2556550054A5049679155 @default.
- W2556550054 hasAuthorship W2556550054A5050087793 @default.
- W2556550054 hasAuthorship W2556550054A5061732223 @default.
- W2556550054 hasAuthorship W2556550054A5070576060 @default.
- W2556550054 hasAuthorship W2556550054A5074664283 @default.
- W2556550054 hasAuthorship W2556550054A5080485119 @default.
- W2556550054 hasAuthorship W2556550054A5081605030 @default.
- W2556550054 hasConcept C101762097 @default.
- W2556550054 hasConcept C104317684 @default.
- W2556550054 hasConcept C125418893 @default.
- W2556550054 hasConcept C128526571 @default.
- W2556550054 hasConcept C137756551 @default.
- W2556550054 hasConcept C140173407 @default.
- W2556550054 hasConcept C150194340 @default.
- W2556550054 hasConcept C153911025 @default.
- W2556550054 hasConcept C159654299 @default.
- W2556550054 hasConcept C170493617 @default.
- W2556550054 hasConcept C190727270 @default.
- W2556550054 hasConcept C203014093 @default.
- W2556550054 hasConcept C2778453870 @default.
- W2556550054 hasConcept C2778461978 @default.
- W2556550054 hasConcept C2781107101 @default.
- W2556550054 hasConcept C2909962599 @default.
- W2556550054 hasConcept C33288867 @default.
- W2556550054 hasConcept C42362537 @default.
- W2556550054 hasConcept C43907098 @default.
- W2556550054 hasConcept C502942594 @default.
- W2556550054 hasConcept C54355233 @default.
- W2556550054 hasConcept C86803240 @default.
- W2556550054 hasConcept C96926380 @default.
- W2556550054 hasConceptScore W2556550054C101762097 @default.
- W2556550054 hasConceptScore W2556550054C104317684 @default.
- W2556550054 hasConceptScore W2556550054C125418893 @default.
- W2556550054 hasConceptScore W2556550054C128526571 @default.
- W2556550054 hasConceptScore W2556550054C137756551 @default.
- W2556550054 hasConceptScore W2556550054C140173407 @default.
- W2556550054 hasConceptScore W2556550054C150194340 @default.
- W2556550054 hasConceptScore W2556550054C153911025 @default.
- W2556550054 hasConceptScore W2556550054C159654299 @default.
- W2556550054 hasConceptScore W2556550054C170493617 @default.
- W2556550054 hasConceptScore W2556550054C190727270 @default.
- W2556550054 hasConceptScore W2556550054C203014093 @default.
- W2556550054 hasConceptScore W2556550054C2778453870 @default.
- W2556550054 hasConceptScore W2556550054C2778461978 @default.
- W2556550054 hasConceptScore W2556550054C2781107101 @default.
- W2556550054 hasConceptScore W2556550054C2909962599 @default.
- W2556550054 hasConceptScore W2556550054C33288867 @default.
- W2556550054 hasConceptScore W2556550054C42362537 @default.
- W2556550054 hasConceptScore W2556550054C43907098 @default.
- W2556550054 hasConceptScore W2556550054C502942594 @default.
- W2556550054 hasConceptScore W2556550054C54355233 @default.
- W2556550054 hasConceptScore W2556550054C86803240 @default.
- W2556550054 hasConceptScore W2556550054C96926380 @default.
- W2556550054 hasLocation W25565500541 @default.
- W2556550054 hasOpenAccess W2556550054 @default.
- W2556550054 hasPrimaryLocation W25565500541 @default.
- W2556550054 hasRelatedWork W1513608376 @default.
- W2556550054 hasRelatedWork W1982929042 @default.
- W2556550054 hasRelatedWork W2270517900 @default.
- W2556550054 hasRelatedWork W2415430629 @default.
- W2556550054 hasRelatedWork W2472606033 @default.
- W2556550054 hasRelatedWork W2536588439 @default.
- W2556550054 hasRelatedWork W2538455610 @default.
- W2556550054 hasRelatedWork W2548403520 @default.
- W2556550054 hasRelatedWork W2553097173 @default.
- W2556550054 hasRelatedWork W2564866573 @default.
- W2556550054 hasRelatedWork W2566455255 @default.
- W2556550054 hasRelatedWork W2588162777 @default.
- W2556550054 hasRelatedWork W2787868133 @default.
- W2556550054 hasRelatedWork W2913880756 @default.